Emily Grezaffi
Pediatrics · Mobile, ALNPI 1033296546
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.9% of the total across 103 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Aytu Biopharma, Inc. at 32.5% of the total. Reporting peaked in 2021 at $416 and has fallen 61.1% since, to $162 in 2025.
Across 103 payments — averaging $15.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aytu Biopharma, Inc.$510
- GSK$187
- Pfizer$184
- Takeda Pharmaceuticals U.S.A., Inc.$115
- Ironshore Pharmaceuticals Inc.$92
- Merck$84
- plus $399 from 15 others
What the payments were for
- Food & beverage$1,55599%
- Education$171%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$1,571 in reported general payments places this provider in the 85th percentile of 908 pediatrics providers in Alabama.
Other pediatrics in Mobile
- James WileyMobile$44K
- Hilary SeayMobile$5K
- Catherine HuettemannMobile$3K
- Richard HuettemannMobile$3K
- Windham TinnellMobile$3K
- Katherine SavellsMobile$2K
- Tamera Coyne-BeasleyBirmingham$154K
- Linda HammettBirmingham$123K
- Darby McElderryBirmingham$111K
- Audrey LloydBirmingham$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.